Nieuws

AHA/ASA Journals17d
Response by Bortolin and Pu to Letter Regarding Article, “Antisense Oligonucleotide Therapy for Calmodulinopathy”
In the recent article, “Antisense Oligonucleotide Therapy for Calmodulinopathy,” we provided the first proof-of-concept in vivo evidence that depletion of CALM1 safely and effectively treated ...